Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline
Authors
Keywords
-
Journal
Viruses-Basel
Volume 14, Issue 11, Pages 2488
Publisher
MDPI AG
Online
2022-11-11
DOI
10.3390/v14112488
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
- (2022) Matthew Gagne et al. CELL
- A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity
- (2022) Peng Du et al. JOURNAL OF MEDICAL VIROLOGY
- Efficacy of a Fourth Dose of Covid-19 mRNA Vaccine against Omicron
- (2022) Gili Regev-Yochay et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection
- (2022) Juan Shi et al. JOURNAL OF VIROLOGY
- Immunogenicity and Safety of Beta-Adjuvanted Recombinant Booster Vaccine
- (2022) Odile Launay et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
- (2022) Chaitanya Kurhade et al. Nature Communications
- Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2
- (2022) Zhenhao Fang et al. Nature Communications
- Neutralizing Potency of Prototype and Omicron RBD mRNA Vaccines Against Omicron Variant
- (2022) Jinkai Zang et al. Frontiers in Immunology
- Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice
- (2022) Irene González-Domínguez et al. Microbiology Spectrum
- Evaluation of humoral immune responses induced by different SARS‐CoV‐2 spike trimers from wild‐type and emerging variants with individual, sequential, and combinational delivered strategies
- (2022) Chengchao Ding et al. JOURNAL OF MEDICAL VIROLOGY
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19
- (2022) Spyros Chalkias et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 prefusion spike protein stabilized by six rather than two prolines is more potent for inducing antibodies that neutralize viral variants of concern
- (2022) Mijia Lu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Replicating RNA platform enables rapid response to the SARS-CoV-2 Omicron variant and elicits enhanced protection in naïve hamsters compared to ancestral vaccine
- (2022) David W. Hawman et al. EBioMedicine
- Bivalent mRNA vaccine booster induces robust antibody immunity against Omicron lineages BA.2, BA.2.12.1, BA.2.75 and BA.5
- (2022) Zhenhao Fang et al. Cell Discovery
- Stabilizing the closed SARS-CoV-2 spike trimer
- (2021) Jarek Juraszek et al. Nature Communications
- Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
- (2021) Changshuo Wei et al. Journal of Genetics and Genomics
- A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
- (2020) Lorena Sanchez-Felipe et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search